Loading...
272 Middle East and Africa Disease Specific Drugs Reports
Country Covered: South Africa
Study Period: 2018 - 2029
Major Players: AstraZeneca, Merck, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis
Country Covered: Saudi Arabia
Study Period: 2018 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Merck and Co., Novo Nordisk A/S, Sanofi Aventis
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Saudi Arabia, Iran, Egypt, Oman, South Africa
Major Players: Boehringer Ingelheim, Astrazeneca, Eli Lilly, Sanofi, Novo Nordisk
Country Covered: Egypt
Study Period: 2019 - 2029
Major Players: AstraZeneca, Boehringer Ingelheim, Novo Nordisk A/S, Sanofi Aventis, Eli Lilly and Company
Region Covered: Middle East and Africa
Study Period: 2018 - 2029
Countries Covered: Egypt, Iran, Oman, Saudi Arabia, South Africa
Major Players: Bristol Myers Squibb, Teva, Sanofi Aventis, Merck and Co., Glenmark Pharmaceuticals
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Bristol Myers Squibb Company, F Hoffmann-La Roche Ltd, Gilead Sciences Inc., Merck KGaA
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M Company , ACell Inc. , BSN medical , Cardinal Health , ConvaTec Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M Company, Becton, Dickinson and Company, Biomerieux SA, Sterigenics International LLC, Johnson and Johnson(Ethicon)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: 3M, Blistex Inc., Colgate- Palmolive Company, Church & Dwight, Inc., GSK plc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Smith & Nephew , Johnson & Johnson, Mölnlycke Health Care AB, 3M Company, Cardinal Health
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: DJO Global, Inc. , Teikoku Pharma USA, Inc, Zimmer Biomet , 3M, AKSIGEN
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Philips, Colgate, DMG Dental, VOCO GmbH, Dentsply Sirona
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Alcon Inc., Bausch Health Companies Inc., Johnson & Johnson, Carl Zeiss Meditec AG, Topcon Corporation
Region Covered: Middle East and Africa
Study Period: 2024 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Sanofi SA, GlaxoSmithKline PLC, F. Hoffmann-La Roche Ltd. (Genentech Inc.), Leti Pharma
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Allergan, Inc., F. Hoffmann-La Roche Ltd, GlaxoSmithKline plc, Lupin Pharmaceuticals, Inc., Pfizer Inc.
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Dermamed Solutions, AbbVie Inc (Allergan, Inc), Obagi Cosmeceuticals LLC, Merz GmbH & Co. KGaA, L'Oréal SA
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Santen Pharmaceutical Co. Ltd, OASIS Medical, Alcon Inc., Bausch Health Companies Inc., AbbVie Inc. (Allergan PLC)
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Amgen, Inc., Teva Pharmaceuticals Industries Ltd., Novartis AG, G1 Therapeutics, BeyondSpring Pharmaceuticals Inc
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Teva Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc, Merck & Co Inc, AbbVie Inc. (Allergan)
Region Covered: Middle East and Africa
Study Period: 2021 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Johnson & Johnson, Novartis AG, Bausch Health, Santen Pharmaceutical Co., Ltd., AbbVie Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Medtronic PLC, Astellas Pharma, Inc., Macleods Pharmaceuticals Ltd, Pfizer, Inc, AbbVie Ltd.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc. (Allergan, Inc.), Merck & Co., Inc.,, Novartis AG, Bausch Health Companies Inc. , Johnson & Johnson
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Takeda Pharmaceutical Company Limited , Bristol-Myers Squibb, LUPIN, Accord Healthcare, Otsuka America Pharmaceutical, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc , Gilead Sciences, Inc, Mylan N.V, Alaxia, Vertex Pharmaceuticals Incorporated
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Novartis AG, AbbVie Inc., Aciont Inc., Amgen, Tarsier Pharma Ltd
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc., Allergan PLC, AstraZeneca Plc, GlaxoSmithKline Plc, Janssen Pharmaceuticals Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Eli Lilly and Company, Pfizer Inc., Johnson and Johnson (Janssen Global Services, LLC), Novartis AG, Amgen Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: Boehringer Ingelheim International GmbH, UCB SA, Novartis AG, Teva Pharmaceutical, Merck & Co Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc, Gilead Sciences, Inc., GlaxoSmithKline plc, F Hoffmann-La Roche, Ltd, Merck & Co, Inc.
Region Covered: Middle East and Africa
Study Period: 2019 - 2029
Countries Covered: United States, Canada, Mexico, Germany, United Kingdom, France, Italy, Spain, China, Japan, India, Australia, South Korea, South Africa, Brazil, Argentina
Major Players: AbbVie Inc. , Eli Lilly and Company , Teva Pharmaceuticals USA, Inc. , Pfizer Inc., GlaxoSmithKline plc.
Filter Reports
By Countries
